Share-based Payment Arrangement, Expense of Teladoc Health, Inc. from 31 Dec 2013 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Teladoc Health, Inc. quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 31 Dec 2013 to 31 Dec 2025.
  • Teladoc Health, Inc. Share-based Payment Arrangement, Expense for the quarter ending 31 Dec 2025 was $15,911,000, a 42% decline year-over-year.
  • Teladoc Health, Inc. Share-based Payment Arrangement, Expense for the twelve months ending 31 Dec 2025 was $80,414,000, a 45% decline year-over-year.
  • Teladoc Health, Inc. annual Share-based Payment Arrangement, Expense for 2025 was $80,414,000, a 45% decline from 2024.
  • Teladoc Health, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $145,951,000, a 28% decline from 2023.
  • Teladoc Health, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $201,550,000, a 7.5% decline from 2022.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

Teladoc Health, Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $80,414,000 $15,911,000 -$11,561,000 -42% 01 Oct 2025 31 Dec 2025 10-K 26 Feb 2026 2025 FY
Q3 2025 $91,975,000 $16,996,000 -$17,051,000 -50% 01 Jul 2025 30 Sep 2025 10-Q 30 Oct 2025 2025 Q3
Q2 2025 $109,026,000 $22,344,000 -$19,763,000 -47% 01 Apr 2025 30 Jun 2025 10-Q 30 Jul 2025 2025 Q2
Q1 2025 $128,789,000 $25,163,000 -$17,162,000 -41% 01 Jan 2025 31 Mar 2025 10-Q 01 May 2025 2025 Q1
Q4 2024 $145,951,000 $27,472,000 -$19,370,000 -41% 01 Oct 2024 31 Dec 2024 10-K 26 Feb 2026 2025 FY
Q3 2024 $165,321,000 $34,047,000 -$18,898,000 -36% 01 Jul 2024 30 Sep 2024 10-Q 30 Oct 2025 2025 Q3
Q2 2024 $184,219,000 $42,107,000 -$13,618,000 -24% 01 Apr 2024 30 Jun 2024 10-Q 30 Jul 2025 2025 Q2
Q1 2024 $197,837,000 $42,325,000 -$3,713,000 -8.1% 01 Jan 2024 31 Mar 2024 10-Q 01 May 2025 2025 Q1
Q4 2023 $201,550,000 $46,842,000 -$3,912,000 -7.7% 01 Oct 2023 31 Dec 2023 10-K 26 Feb 2026 2025 FY
Q3 2023 $205,462,000 $52,945,000 -$2,717,000 -4.9% 01 Jul 2023 30 Sep 2023 10-Q 31 Oct 2024 2024 Q3
Q2 2023 $208,179,000 $55,725,000 +$4,725,000 +9.3% 01 Apr 2023 30 Jun 2023 10-Q 01 Aug 2024 2024 Q2
Q1 2023 $203,454,000 $46,038,000 -$14,398,000 -24% 01 Jan 2023 31 Mar 2023 10-Q 26 Apr 2024 2024 Q1
Q4 2022 $217,852,000 $50,754,000 -$10,861,000 -18% 01 Oct 2022 31 Dec 2022 10-K 27 Feb 2025 2024 FY
Q3 2022 $228,713,000 $55,662,000 -$16,039,000 -22% 01 Jul 2022 30 Sep 2022 10-Q 27 Oct 2023 2023 Q3
Q2 2022 $244,752,000 $51,000,000 -$31,970,000 -39% 01 Apr 2022 30 Jun 2022 10-Q 28 Jul 2023 2023 Q2
Q1 2022 $276,722,000 $60,436,000 -$25,864,000 -30% 01 Jan 2022 31 Mar 2022 10-Q 02 May 2023 2023 Q1
Q4 2021 $302,586,000 $61,615,000 -$352,765,000 -85% 01 Oct 2021 31 Dec 2021 10-K 23 Feb 2024 2023 FY
Q3 2021 $655,351,000 $71,701,000 +$50,793,000 +243% 01 Jul 2021 30 Sep 2021 10-Q 02 Nov 2022 2022 Q3
Q2 2021 $604,558,000 $82,970,000 +$61,042,000 +278% 01 Apr 2021 30 Jun 2021 10-Q 03 Aug 2022 2022 Q2
Q1 2021 $543,516,000 $86,300,000 +$67,985,000 +371% 01 Jan 2021 31 Mar 2021 10-Q 02 May 2022 2022 Q1
Q4 2020 $475,531,000 $414,380,000 +$395,923,000 +2145% 01 Oct 2020 31 Dec 2020 10-K 01 Mar 2023 2022 FY
Q3 2020 $79,608,000 $20,908,000 +$3,554,000 +20% 01 Jul 2020 30 Sep 2020 10-Q 01 Nov 2021 2021 Q3
Q2 2020 $76,054,000 $21,928,000 +$4,560,000 +26% 01 Apr 2020 30 Jun 2020 10-Q 02 Aug 2021 2021 Q2
Q1 2020 $71,494,000 $18,315,000 +$4,792,000 +35% 01 Jan 2020 31 Mar 2020 10-Q 03 May 2021 2021 Q1
Q4 2019 $66,702,000 $18,457,000 +$5,775,000 +46% 01 Oct 2019 31 Dec 2019 10-K 28 Feb 2022 2021 FY
Q3 2019 $60,927,000 $17,354,000 +$5,159,000 +42% 01 Jul 2019 30 Sep 2019 10-Q 06 Nov 2020 2020 Q3
Q2 2019 $55,768,000 $17,368,000 +$6,308,000 +57% 01 Apr 2019 30 Jun 2019 10-Q 29 Jul 2020 2020 Q2
Q1 2019 $49,460,000 $13,523,000 +$5,691,000 +73% 01 Jan 2019 31 Mar 2019 10-Q 29 Apr 2020 2020 Q1
Q4 2018 $43,769,000 $12,682,000 -$4,287,000 -25% 01 Oct 2018 31 Dec 2018 10-K 01 Mar 2021 2020 FY
Q3 2018 $48,056,000 $12,195,000 +$6,229,000 +104% 01 Jul 2018 30 Sep 2018 10-Q 30 Oct 2019 2019 Q3
Q2 2018 $41,827,000 $11,060,000 +$6,495,000 +142% 01 Apr 2018 30 Jun 2018 10-Q 31 Jul 2019 2019 Q2
Q1 2018 $35,332,000 $7,832,000 +$4,735,000 +153% 01 Jan 2018 31 Mar 2018 10-Q 30 Apr 2019 2019 Q1
Q4 2017 $30,597,000 $16,969,000 +$14,333,000 +544% 01 Oct 2017 31 Dec 2017 10-K 26 Feb 2020 2019 FY
Q3 2017 $16,264,000 $5,966,000 +$3,801,000 +176% 01 Jul 2017 30 Sep 2017 10-Q 01 Nov 2018 2018 Q3
Q2 2017 $12,463,000 $4,565,000 +$2,931,000 +179% 01 Apr 2017 30 Jun 2017 10-Q 01 Aug 2018 2018 Q2
Q1 2017 $9,532,000 $3,097,000 +$1,809,000 +140% 01 Jan 2017 31 Mar 2017 10-Q 01 May 2018 2018 Q1
Q4 2016 $7,723,000 $2,636,000 +$1,658,000 +170% 01 Oct 2016 31 Dec 2016 10-K 27 Feb 2019 2018 FY
Q3 2016 $6,065,000 $2,165,000 +$1,446,000 +201% 01 Jul 2016 30 Sep 2016 10-Q 01 Nov 2017 2017 Q3
Q2 2016 $4,619,000 $1,634,000 +$1,067,000 +188% 01 Apr 2016 30 Jun 2016 10-Q 02 Aug 2017 2017 Q2
Q1 2016 $3,552,000 $1,288,000 +$477,000 +59% 01 Jan 2016 31 Mar 2016 10-Q 08 May 2017 2017 Q1
Q4 2015 $3,075,000 $978,000 01 Oct 2015 31 Dec 2015 10-K 27 Feb 2018 2017 FY
Q3 2015 $719,000 +$601,000 +509% 01 Jul 2015 30 Sep 2015 10-Q 27 Oct 2016 2016 Q3
Q2 2015 $567,000 +$419,000 +283% 01 Apr 2015 30 Jun 2015 10-Q 03 Aug 2016 2016 Q2
Q1 2015 $811,000 01 Jan 2015 31 Mar 2015 10-Q 10 May 2016 2016 Q1
Q3 2014 $118,000 01 Jul 2014 30 Sep 2014 10-Q 02 Nov 2015 2015 Q3
Q2 2014 $148,000 01 Apr 2014 30 Jun 2014 10-Q 12 Aug 2015 2015 Q2

Teladoc Health, Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $80,414,000 -$65,537,000 -45% 01 Jan 2025 31 Dec 2025 10-K 26 Feb 2026 2025 FY
2024 $145,951,000 -$55,599,000 -28% 01 Jan 2024 31 Dec 2024 10-K 26 Feb 2026 2025 FY
2023 $201,550,000 -$16,302,000 -7.5% 01 Jan 2023 31 Dec 2023 10-K 26 Feb 2026 2025 FY
2022 $217,852,000 -$84,734,000 -28% 01 Jan 2022 31 Dec 2022 10-K 27 Feb 2025 2024 FY
2021 $302,586,000 -$172,945,000 -36% 01 Jan 2021 31 Dec 2021 10-K 23 Feb 2024 2023 FY
2020 $475,531,000 +$408,829,000 +613% 01 Jan 2020 31 Dec 2020 10-K 01 Mar 2023 2022 FY
2019 $66,702,000 +$22,933,000 +52% 01 Jan 2019 31 Dec 2019 10-K 28 Feb 2022 2021 FY
2018 $43,769,000 +$13,172,000 +43% 01 Jan 2018 31 Dec 2018 10-K 01 Mar 2021 2020 FY
2017 $30,597,000 +$22,874,000 +296% 01 Jan 2017 31 Dec 2017 10-K 26 Feb 2020 2019 FY
2016 $7,723,000 +$4,648,000 +151% 01 Jan 2016 31 Dec 2016 10-K 27 Feb 2019 2018 FY
2015 $3,075,000 +$2,542,000 +477% 01 Jan 2015 31 Dec 2015 10-K 27 Feb 2018 2017 FY
2014 $533,000 +$235,000 +79% 01 Jan 2014 31 Dec 2014 10-K 01 Mar 2017 2016 FY
2013 $298,000 01 Jan 2013 31 Dec 2013 10-K 03 Mar 2016 2015 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.